0 Ratings

ID

34272

Description

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522

Link

https://clinicaltrials.gov/show/NCT01510522

Keywords

  1. 1/16/19 1/16/19 -
  2. 5/14/19 5/14/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    Description

    ID.1

    Data type

    boolean

    on treatment with metformin tablets
    Description

    ID.2

    Data type

    boolean

    patients with at least 2 treated co-morbidities
    Description

    ID.3

    Data type

    boolean

    established dose of metformin > 1.700 mg/day
    Description

    ID.4

    Data type

    boolean

    age > 18 years old
    Description

    ID.5

    Data type

    boolean

    given informed consent
    Description

    ID.6

    Data type

    boolean

    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    patients not able to take medication orally
    Description

    ID.7

    Data type

    boolean

    according to summary of product characteristics (smpc)
    Description

    ID.8

    Data type

    boolean

    participating in another clinical trial 30 days prior to randomization
    Description

    ID.9

    Data type

    boolean

    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    Description

    ID.10

    Data type

    boolean

    Similar models

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    boolean
    ID.2
    Item
    on treatment with metformin tablets
    boolean
    ID.3
    Item
    patients with at least 2 treated co-morbidities
    boolean
    ID.4
    Item
    established dose of metformin > 1.700 mg/day
    boolean
    ID.5
    Item
    age > 18 years old
    boolean
    ID.6
    Item
    given informed consent
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.7
    Item
    patients not able to take medication orally
    boolean
    ID.8
    Item
    according to summary of product characteristics (smpc)
    boolean
    ID.9
    Item
    participating in another clinical trial 30 days prior to randomization
    boolean
    ID.10
    Item
    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial